Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer of Bone”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06372717
What this trial is testing

Investigate APL-4098 Alone and in Combination in Adults With AML or MDS

Who this might be right for
Acute Myeloid Leukemia RefractoryMyelodysplastic Syndrome Acute Myeloid LeukemiaMyelodysplastic Syndrome With Excess Blasts+2 more
Apollo Therapeutics Ltd 100
Large-scale testing (Phase 3)Study completedNCT01920568
What this trial is testing

Compare Denosumab With Zoledronic Acid in Subjects With Bone Metastases From Solid Tumors

Who this might be right for
Fractures, Bone
GlaxoSmithKline 487
Not applicableStudy completedNCT02084147
What this trial is testing

PET-MRI in Diagnosing Patients With Cancer, Cardiac Diseases, or Neurologic Diseases

Who this might be right for
Cardiac DiseaseDementiaInflammatory Disease+4 more
Case Comprehensive Cancer Center 72
Testing effectiveness (Phase 2)Study completedNCT00849147
What this trial is testing

Bone Marrow Transplant From Partially Matched Donors and Nonmyeloablative Conditioning for Blood Cancers (BMT CTN 0603)

Who this might be right for
Precursor B-Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myeloid, AcuteBurkitt Lymphoma+3 more
Medical College of Wisconsin 55
Post-approval studies (Phase 4)Study completedNCT01200355
What this trial is testing

Posaconazole Versus Micafungin for Prophylaxis Against Invasive Fungal Infections During Neutropenia in Patients Undergoing Chemotherapy for Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia or Myelodysplastic Syndrome

Who this might be right for
Acute Myelogenous LeukemiaMyelodysplastic Syndrome
Memorial Sloan Kettering Cancer Center 113
Testing effectiveness (Phase 2)Study completedNCT00132015
What this trial is testing

17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Systemic Mastocytosis

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
National Institutes of Health Clinical Center (CC) 37
Testing effectiveness (Phase 2)Study completedNCT01009840
What this trial is testing

IV Busulfan Plus Bortezomib Conditioning Regimen for Second Autologous Stem Cell Transplant in Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
Otsuka Pharmaceutical Development & Commercialization, Inc. 30
Testing effectiveness (Phase 2)Looking for participantsNCT07602049
What this trial is testing

Cryoablation Plus Camrelizumab for Advanced Soft Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma (STS)Osteosarcoma
Sun Yat-sen University 57
Testing effectiveness (Phase 2)Study completedNCT03149055
What this trial is testing

Fungal Prophylaxis With Isavuconazole for Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (HCT)

Who this might be right for
Hematologic MalignancyMyeloproliferative Disorder
Memorial Sloan Kettering Cancer Center 99
Early research (Phase 1)Study completedNCT01031368
What this trial is testing

Clofarabine, Cytarabine, and Filgrastim Followed by Infusion of Non-HLA Matched Ex Vivo Expanded Cord Blood Progenitors in Treating Patients With Acute Myeloid Leukemia

Who this might be right for
Adult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Monoblastic Leukemia (M5a)+15 more
Nohla Therapeutics, Inc. 29
Testing effectiveness (Phase 2)Temporarily pausedNCT01211691
What this trial is testing

Study of KB004 in Subjects With Hematologic Malignancies (Myelodysplastic Syndrome, MDS, Myelofibrosis, MF)

Who this might be right for
Myelodysplastic Syndrome (MDS)Myelofibrosis (MF)
Humanigen, Inc. 120
Early research (Phase 1)Study completedNCT02044120
What this trial is testing

ESP1/SARC025 Global Collaboration: A Phase I Study of a Combination of the PARP Inhibitor, Niraparib and Temozolomide and/or Irinotecan Patients With Previously Treated, Incurable Ewing Sarcoma

Who this might be right for
Ewing Sarcoma
Sarcoma Alliance for Research through Collaboration 34
Not applicableUnknownNCT03131986
What this trial is testing

Cessation of Tyrosine Kinase Inhibitors in Patients With Chronic-phase Chronic Myelogenous Leukaemia

Who this might be right for
Leukemia, Myelogenous, Chronic Phase
The University of Hong Kong 30
Testing effectiveness (Phase 2)Study completedNCT00119340
What this trial is testing

Fludarabine, Total-Body Irradiation, and Donor Stem Cell Transplant Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients With Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
Fred Hutchinson Cancer Center 75
Testing effectiveness (Phase 2)Looking for participantsNCT04515459
What this trial is testing

Efficacy of Pre-operative Prehabilitation in Patients With Limb Sarcoma

Who this might be right for
Sarcoma
Institut Claudius Regaud 53
Testing effectiveness (Phase 2)Ended earlyNCT00172068
What this trial is testing

Zoledronic Acid in the Treatment of Breast Cancer With Minimal Residual Disease in the Bone Marrow

Who this might be right for
Primary Breast Cancer
Novartis Pharmaceuticals 96
Early research (Phase 1)WithdrawnNCT02871323
What this trial is testing

Durvalumab in Treating Patients With Primary, Post-Polycythemia Vera, or Post-Essential Thrombocythemia Myelofibrosis

Who this might be right for
Polycythemia Vera, Post-Polycythemic Myelofibrosis PhasePrimary Myelofibrosis
Northwestern University
Early research (Phase 1)Study completedNCT00006213
What this trial is testing

BMS-214662 in Treating Patients With Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myeloid Leukemia

Who this might be right for
Adult Acute Promyelocytic Leukemia (M3)Blastic Phase Chronic Myelogenous LeukemiaChildhood Myelodysplastic Syndromes+8 more
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)UnknownNCT03356080
What this trial is testing

DLAAG in the Treatment of Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome With Blast Excess

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
Shanghai Tong Ren Hospital 50
Early research (Phase 1)Ended earlyNCT01130688
What this trial is testing

Safety of Zileuton (Zyflo) in Combination With Imatinib Mesylate (Gleevec) in CML.

Who this might be right for
Chronic Myelogenous Leukemia
University of Massachusetts, Worcester 2
Next Page